You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Sovaldi

Showing 1 - 25 of 101
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

HCV Trial in Cairo (Sofosbuvir 200 MG Oral Tablet plus Daclatasvir 30 mg Oral tablets)

Recruiting
  • HCV
  • Sofosbuvir 200 MG Oral Tablet plus Daclatasvir 30 mg Oral tablets
  • Cairo, Egypt
    Faculty of Medicine, Ain-Shams University Research Institute-Cli
May 2, 2023

Hepatitis C Trial in Darlinghurst, Sydney, Adelaide (Sofosbuvir 400mg [Sovaldi], Glecaprevir/pibrentasvir (300mg/120mg))

Recruiting
  • Hepatitis C
  • Sofosbuvir 400mg [Sovaldi]
  • Glecaprevir/pibrentasvir (300mg/120mg)
  • Darlinghurst, New South Wales, Australia
  • +2 more
Mar 28, 2022

Hepatitis B Trial in Baltimore (Ledipasvir 90 MG / Sofosbuvir 400 MG Oral Tablet [Harvoni], Sofosbuvir 400 MG [Sovaldi],

Completed
Has Results
  • Hepatitis B
  • Ledipasvir 90 MG / Sofosbuvir 400 MG Oral Tablet [Harvoni]
  • +2 more
  • Baltimore, Maryland
    Institute of Human Virology (IHV), University of Maryland Baltim
Aug 24, 2021

HIV-1-infection, Hepatic Impairment Trial in Smolensk (Elpida®, Dolutegravir, Sofosbuvir)

Completed
  • HIV-1-infection
  • Hepatic Impairment
  • Smolensk, Russian Federation
    Regional State Budgetary Healthcare Institution "Smolensk Region
Jan 10, 2022

Sovaldi in Chronic Hepatitis C Virus (HCV) Infection in Korea

Completed
  • Hepatitis C Virus
  • Wonju, Gangwon-do, Korea, Republic of
  • +71 more
Dec 23, 2021

Chronic Hepatitis C Infection, HBV Coinfection, Hepatitis B Reactivation Trial in Hong Kong (Ledipasvir/Sofosbuvir, Sofosbuvir

Completed
  • Chronic Hepatitis C Infection
  • +2 more
  • Hong Kong, Hong Kong, China
    Humanity and Health GI and Liver Centre
Aug 27, 2021

Chronic Hepatitis C, Hepatitis C Virus, Genotype 3 Hepatitis C Virus Trial (ABT-493/ABT-530, Sofosbuvir, Daclatasvir)

Completed
Has Results
  • Chronic Hepatitis C
  • +2 more
  • (no location specified)
Jul 9, 2021

Hepatitis C Trial in Worldwide (SOF/VEL for 6 weeks, SOF/VEL for 12 weeks)

Completed
Has Results
  • Hepatitis C
  • SOF/VEL for 6 weeks
  • SOF/VEL for 12 weeks
  • Baltimore, Maryland
  • +24 more
Nov 22, 2021

Hepatitis C, Chronic Trial in Chennai (Sofosbuvir, Pegylated Interferon alfa-2a, Ribavirin)

Completed
Has Results
  • Hepatitis C, Chronic
  • Chennai, Tamil Nadu, India
    YR Gaitonde Centre for AIDS Research and Education
Mar 22, 2021

Chronic Hepatitis C Virus Infection Trial (OBV/PTV/r, Sofosbuvir, Ribavirin (RBV))

Completed
Has Results
  • Chronic Hepatitis C Virus Infection
  • (no location specified)
Jul 8, 2021

Hepatitis C, Chronic Trial in Bilaspur (Sofosbuvir, Daclatasvir, Pegylated Interferon alfa-2a)

Completed
Has Results
  • Hepatitis C, Chronic
  • Bilaspur, Chhattisgarh, India
    YR Gaitonde Centre for AIDS Education and Johns Hopkins Universi
Apr 26, 2021

Chronic Hepatitis C Virus Infection Trial ((SOF and DCV), (SOF, DCV, and RBV))

Completed
  • Chronic Hepatitis C Virus Infection
  • (SOF and DCV)
  • (SOF, DCV, and RBV)
  • (no location specified)
May 13, 2020

OF OCT-A TO Detect Possible Retinal Vascular Complications of

Unknown status
  • HCV Infection
  • Optical coherence tomography angiography
  • Sofosbuvir (Sovaldi)
  • Cairo, Egypt
    Cairo University - Kasr Alainy
Nov 7, 2019

the Pulmonary Safety of Antihepatitis C Treatment

Not yet recruiting
  • Hepatitis C
  • sofosbuvir \daclatsvir
  • (no location specified)
Mar 26, 2020

Hepatitis C Infection Trial in United States (MBL-HCV1, Telaprevir (Part 1), Sofosbuvir (Part 2))

Terminated
Has Results
  • Hepatitis C Infection
  • MBL-HCV1
  • +2 more
  • Boston, Massachusetts
  • +4 more
Feb 4, 2021

Healthy Trial in Cairo (Sofodelevier, Sovaldi (fist dose), Sovaldi (second dose))

Completed
  • Healthy
  • Cairo, Egypt
    Genuine Research Center GRC
Jul 30, 2019

Chronic Hepatitis C Virus Infection Trial (Sofosbuvir + Simeprevir + Ribavirin)

Completed
  • Chronic Hepatitis C Virus Infection
  • Sofosbuvir + Simeprevir + Ribavirin
  • (no location specified)
May 9, 2020

Hepatitis C Trial in Tanta (Sofosbuvir, Ribavirin, Pegylated-interferon alfa-2a)

Completed
  • Hepatitis C
  • Tanta, Egypt
  • +1 more
Aug 1, 2020

Chronic Hepatitis C Virus Infection Trial in Bani Sweif (SOF/SMV/DCV/RBV)

Completed
  • Chronic Hepatitis C Virus Infection
  • Bani Sweif, Egypt
    Health Administration at Beni-Seuf
May 10, 2020

Chronic Hepatitis C Virus Infection Trial in Beni-Suef (SOF plus (OBV/PTV/r) plus RBV)

Completed
  • Chronic Hepatitis C Virus Infection
  • SOF plus (OBV/PTV/r) plus RBV
  • Beni-Suef, Egypt
    Beni-Suef University
May 13, 2020

Hepatitis C Trial in United States (DCV/ASV/BMS-791325, Ribavirin, Sofosbuvir)

Completed
Has Results
  • Hepatitis C
  • Rialto, California
  • +6 more
Aug 7, 2020

Chronic Hepatitis C Trial in Cairo (sofosbuvir plus daclatasvir, Sofosbuvir plus Ledipasvir)

Unknown status
  • Chronic Hepatitis C
  • sofosbuvir plus daclatasvir
  • Sofosbuvir plus Ledipasvir
  • Cairo, Abbasseya, Egypt
    El Demerdash Hospital
Dec 28, 2019

Hepatitis C Virus Infection Trial in Worldwide (Sofosbuvir (SOF), Ledipasvir/Sofosbuvir (LDV/SOF), Sofosbuvir/Velpatasvir

Terminated
  • Hepatitis C Virus Infection
  • Sofosbuvir (SOF)
  • +3 more
  • Phoenix, Arizona
  • +50 more
Jan 25, 2023

Hepatitis C Virus Infection Trial in China (Seraprevir, Sofosbuvir)

Unknown status
  • Hepatitis C Virus Infection
  • Beijing, Beijing, China
  • +3 more
Sep 30, 2019

Hepatitis C Trial (Grazoprevir, Elbasvir, Ribavirin)

Completed
Has Results
  • Hepatitis C
  • (no location specified)
Aug 5, 2019